Enliven Therapeutics, Inc. (ELVN) Insider Traders

$19.61

south_east
-$0.31 (-1.56%)
Day's range
$19.02
Day's range
$20.19

Enliven Therapeutics, Inc. Insider Transactions

Enliven Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
Ballal Rahul D.

Director

Sell 10,420 @ $28.17 $293.56 K 22,341 10/08/2024 10/10/2024
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 1,270 @ $27.51 $34.94 K 0 10/07/2024 10/08/2024
Sell 2,730 @ $27.50 $75.08 K 1,033,793 10/07/2024 10/08/2024
Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

Sell 2,707 @ $27.61 $74.73 K 1,067,180 10/07/2024 10/08/2024
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 10,218 @ $27.51 $281.08 K 0 10/04/2024 10/08/2024
Sell 2,825 @ $27.51 $77.70 K 125,760 10/04/2024 10/08/2024
Sell 12,206 @ $27.51 $335.79 K 1,036,523 10/04/2024 10/08/2024
Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

Sell 7,522 @ $27.51 $206.94 K 1,069,887 10/04/2024 10/08/2024
Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

Sell 527 @ $27.54 $14.51 K 1,077,409 10/01/2024 10/03/2024
Sell 526 @ $27.54 $14.49 K 1,048,729 10/01/2024 10/03/2024
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 521 @ $27.54 $14.35 K 0 10/01/2024 10/03/2024
Showing 41 to 51 of 51 results
Page 3 of 3

Enliven Therapeutics, Inc. FAQ's

The list of insiders at Enliven Therapeutics, Inc. includes Hohl Benjamin, Patel Anish, Kintz Samuel, Lyssikatos Joseph P.

Insiders have sold a total of 95.37 K Enliven Therapeutics, Inc. shares in the last 12 months for a total of 2.07 M sold.

The following insiders have sold Enliven Therapeutics, Inc. shares in the last 12 months: Hohl Benjamin ($370.37 K), Patel Anish ($1.10 M), Kintz Samuel ($342.42 K), Lyssikatos Joseph P ($257.58 K),